Glaxosmithkline | DEUDA



Debt Cambio Fecha
AbbVie USD 67.14B 3.94B 2024-12
Amgen USD 60.1B 299M 2024-12
AstraZeneca USD 30.3B 1.27B 2024-12
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.51B 153M 2024-09
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Glaxosmithkline GBP 16.99B 927M 2024-12
Indivior 329M 4M 2025-03
J&J USD 36.63B 883M 2024-12
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Pacira USD 585.32M 2.04M 2024-12
Perrigo USD 3.62B 1.14B 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Prestige Brands USD 996.95M 54.86M 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda JPY 4.84T 211.04B 2024-12
Teva Pharmaceutical Industries USD 18.08B 901M 2024-12
Zoetis USD 6.57B 4M 2024-12



Glaxosmithkline DEUDA - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.